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Waterborne Disease Outbreaks
In the United States, 127 drinking water outbreaks, most
of them associated with groundwater systems, were reported
to CDC from 1990 through 1998. The number of outbreaks has
declined over the last 20 years, probably as a result of actions
by the U.S. Environmental Protection Agency (EPA), water
utilities, and public health officials; however, changes in
reporting practices may also have contributed to this trend.
World Water Issues
Paul R. Hunter, consultant medical microbiologist and
director of the Chester Public Health Laboratory and
honorary professor of epidemiology and public health at the
University of Central Lancashire, presented World Health
Organization data that showed high morbidity and death
rates worldwide due to consumption of unsafe drinking water.
Currently, about 20% of the world’s population lacks access to
safe drinking water, and more than 5 million people die
annually from illnesses associated with unsafe drinking
water or inadequate sanitation. If everyone had safe drinking
water and adequate sanitation services, there would be 200
million fewer cases of diarrhea and 2.1 million fewer deaths
caused by diarrheal illness each year.
Dr. Hunter noted the wide variety of microbes recognized
since 1980 as waterborne disease agents, including
Cryptosporidium,  Cyclospora,  Escherichia coli O157:H7,
Legionella, Helicobacter pylori, hepatitis E virus, Toxoplas-
ma, and others. The factors that contribute to the emergence
and spread of disease agents are ecologic changes (including
those caused by human activity), international travel and
commerce, technology, human demographics and behavior,
microbial evolution, and the breakdown of public health
systems. Dr. Hunter warned that global freshwater
consumption rose sixfold between 1900 and 1995, and that
this places increasing stress on available drinking water
reserves. This increasing stress will result in ecologic damage
from over-extraction from rivers, saltwater intrusion into
groundwater from over-extraction of groundwater, more
highly contaminated water sources, and the potential
struggle for access to water. Dr. Hunter concluded his
presentation by discussing the threat of biological terrorism
via microbes that could be used for deliberate contamination
of the water supply.
Methodologic Issues in the
Evaluation of Waterborne Disease
Jack M. Colford, assistant professor of epidemiology, at
the University of California-Berkeley, discussed methods for
estimating the incidence of infectious diseases attributable to
the consumption of tap water. In a previously published
study, investigators in Canada compared the incidence of
gastroenteritis in homes with and without a reverse-osmosis
filter. The study showed that 35% of gastrointestinal illness
in the community studied was attributable to drinking water.
The study was randomized, but participants knew in which
group they were enrolled. As a partial consequence of this
study, when Congress amended the Safe Drinking Water Act
in 1996, it required that EPA and CDC develop a national
estimate of waterborne disease occurrence in the United
States. In response, CDC and EPA jointly convened a series of
workshops and consensus panel meetings to develop an
approach to meet this mandate.
As a result of these meetings, EPA and CDC are
supporting several studies, the largest of which will be a
randomized, blinded, placebo-controlled trial, involving
treatment of in-house drinking water. A pilot study of this
intervention trial was recently conducted with residents in 74
homes in northern California; some residents received an
active water treatment device containing a 1-µm filter and
ultraviolet (UV) light for disinfection, and others received a
placebo—the same device without a filter or UV light. Results
from this study and a similar study in Australia should be
released in fall 2000. Other studies employing the same
design will include persons using a groundwater system in
Davenport, Iowa; HIV-positive persons in San Francisco; and
elderly persons in Sonoma, California. The results of these
studies will be used to estimate the percentage of
gastrointestinal disease associated with different types of
drinking water. When compared with the total prevalence
of gastrointestinal disease in the United States, these
results will provide an estimate of the national burden of
waterborne disease caused by drinking water.
Biofilms
Mark W. LeChevallier, director of research at the
American Water Works Service Company, discussed health
concerns regarding biofilms in the drinking water
distribution system. Biofilms are coatings of organic and
inorganic materials in pipes that can harbor, protect, and
allow the proliferation of several bacterial pathogens,
including  Legionella and Mycobacterium avium complex
(MAC). Factors that affect bacterial growth on biofilms
include water temperature, type of disinfectant and residual
concentration, assimilable organic carbon level, biodegrad-
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able organic carbon level, degree of pipe corrosion, and
treatment/distribution system characteristics. Chloramine is
considerably more effective than chlorine for controlling
Legionella in biofilms, presumably because chloramine is
more stable and thus less reactive than chlorine, allowing it to
penetrate the biofilm more deeply.
An important factor in distribution system contamina-
tion and bacterial growth on biofilms is transient water
pressure fluctuations that create pressure waves that pass
through pipes in the distibution system. During the negative
portion of the pressure wave, a substantial amount of
contaminated water (>1 gal per minute) from the outside can
be pulled into pipes through a small leak. This problem is
aggravated when sewer lines are placed close to water pipes.
Dr. LeChevallier stated that a number of waterborne disease
outbreaks have been linked to distribution system
deficiencies. Among the agents of nosocomial waterborne
disease is MAC. This opportunistic bacterial pathogen lives in
water, is resistant to water disinfection (much more so than
Giardia cysts), and grows in pipe biofilms.
During transitional periods new scientific understand-
ings bring new questions. The pivotal issues in xenotrans-
plantation concern biohazards. The U.S. Public Health
Service defines xenotransplantation as “. . . any procedure
that involves the transplantation, implantation, or infusion
into a human recipient of either A) live cells, tissues, or organs
from a nonhuman animal source or B) human body fluids,
cells, tissues, or organs that have had ex vivo contact with live
nonhuman animal cells, tissues, or organs.”
Prior to 1990, xenotransplants were largely whole organs;
recipients survived only days or weeks. However, in most
recent xenotransplantation trials, immunoprotected porcine
neurologic, pancreatic, and hepatic cells are used to treat
degenerative neurologic disorders, diabetes, or hepatic failure.
Increasingly, xenotransplantation products function for
prolonged periods in recipients who survive months or years.
Xenotransplantation is a public health concern because it
has the potential to infect human recipients with agents that
do not ordinarily infect humans, thereby introducing new
infections to humans. Therefore, xenotransplantation
combines a potential benefit with a potential risk to humans
that is presently unknown.
Xenogeneic infections belong to a larger category of
“bioproduct-acquired” infections, an example of which is
simian virus 40 (SV40). SV40, a polyomavirus, contaminated
polio vaccine stocks in the 1950s. Investigations into whether
SV40 infection is associated with an increased risk of cancer
have been inconclusive. This lingering uncertainty about the
long-term significance of apparently innocuous persistent
human infection with nonhuman viruses underscores the
potential for therapeutic use of bioproducts to have
unintended consequences.
The PHS Guideline on Infectious Disease Issues in
Xenotransplantation describes a system of safeguards built
around two key concepts: pretransplant screening of some
animal herds, source animals, and xenotransplantation
products to minimize the risk of xenogeneic infections with
recognized pathogens and posttransplant surveillance of
recipients for previously unrecognized xenogeneic organisms.
Endogenous retroviruses exist as inactive proviral DNA
in the germline of all mammals adequately studied to date.
However, inactive genomic endogenous retroviruses can often
express active virus capable of infecting human cell lines in
vitro. Thus, xenotransplantation products contain benign
genomic DNA that, on transfer into a human, may express
infectious retrovirus capable of creating active, persistent
infection. The importance of this infectious potential of
animal tissue devoid of any identifiable exogenous
microorganisms has been the subject of much concern and
scientific inquiry over the past 5 years.
To date, limited studies on humans exposed to pig cells
and tissues have produced no evidence of porcine endogenous
retrovirus infection. However, the persistent presence of
microchimeric xenogeneic pig cells in the human recipient
confirms that even temporary exposure to xenotransplanta-
tion products may continuously expose humans to infectious
agents contained within them. For this reason, it is argued
that humans should not be exposed to xenotransplantation
products containing infectious agents whose ability to infect,
cause disease in, or be spread among humans is incompletely
defined.
Xenotransplantation is a process that occurs under
controlled circumstances; thus, measures can be implement-
ed to minimize associated iatrogenic biohazards. Studies
performed in the service of developing policies on
xenotransplantation can model other approaches to science-
based risk minimization used for other bioproducts.
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